CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
84 hedge funds and large institutions have $730M invested in Crescent Biopharma, Inc. Common Stock in 2018 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 21 reducing their positions, and 24 closing their positions.
Holders
84
Holders Change
–
Holders Change %
0%
% of All Funds
1.93%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
24
Increased
31
Reduced
21
Closed
24
Calls
$1.53M
Puts
$1.02M
Net Calls
+$519K
Net Calls Change
-$3.72M
Top Buyers
1 |
1
BlackRock
New York
|
$45.2M |
2 |
2
T. Rowe Price Associates
Baltimore,
Maryland
|
$55.6M |
3 |
NMC
3
NEA Management Company
Timonium,
Maryland
|
$147M |
4 |
O
4
OppenheimerFunds
New York
|
$47.8M |
5 |
5
Northern Trust
Chicago,
Illinois
|
$6.71M |